Denali Therapeutics Inc is a biotechnology business based in the US. Denali Therapeutics shares (DNLI) are listed on the NASDAQ and all prices are listed in US Dollars. Denali Therapeutics employs 311 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Denali Therapeutics
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – DNLI – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
Denali Therapeutics stock price (NASDAQ: DNLI)Use our graph to track the performance of DNLI stocks over time.
Denali Therapeutics shares at a glance
|Latest market close||$63.59|
|52-week range||$22.75 - $93.94|
|50-day moving average||$71.46|
|200-day moving average||$64.93|
|Wall St. target price||$79.89|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$0.49|
Buy Denali Therapeutics shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Denali Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Denali Therapeutics price performance over time
|1 week (2021-07-14)||N/A|
|1 month (2021-06-25)||-14.85%|
|3 months (2021-04-21)||N/A|
|6 months (2021-01-21)||N/A|
|1 year (2020-07-21)||N/A|
|2 years (2019-07-21)||N/A|
|3 years (2018-07-21)||N/A|
|5 years (2016-07-21)||N/A|
Is Denali Therapeutics under- or over-valued?
Valuing Denali Therapeutics stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Denali Therapeutics's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Denali Therapeutics's P/E ratio
Denali Therapeutics's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 131x. In other words, Denali Therapeutics shares trade at around 131x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Denali Therapeutics's EBITDA
Denali Therapeutics's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $60 million.
The EBITDA is a measure of a Denali Therapeutics's overall financial performance and is widely used to measure a its profitability.
Denali Therapeutics financials
|Revenue TTM||$340 million|
|Operating margin TTM||15.14%|
|Gross profit TTM||$123 million|
|Return on assets TTM||2.87%|
|Return on equity TTM||7.01%|
|Market capitalisation||$7.8 billion|
TTM: trailing 12 months
Shorting Denali Therapeutics shares
There are currently 5.5 million Denali Therapeutics shares held short by investors – that's known as Denali Therapeutics's "short interest". This figure is 2.1% up from 5.4 million last month.
There are a few different ways that this level of interest in shorting Denali Therapeutics shares can be evaluated.
Denali Therapeutics's "short interest ratio" (SIR)
Denali Therapeutics's "short interest ratio" (SIR) is the quantity of Denali Therapeutics shares currently shorted divided by the average quantity of Denali Therapeutics shares traded daily (recently around 808509.83847283). Denali Therapeutics's SIR currently stands at 6.81. In other words for every 100,000 Denali Therapeutics shares traded daily on the market, roughly 6810 shares are currently held short.
However Denali Therapeutics's short interest can also be evaluated against the total number of Denali Therapeutics shares, or, against the total number of tradable Denali Therapeutics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Denali Therapeutics's short interest could be expressed as 0.05% of the outstanding shares (for every 100,000 Denali Therapeutics shares in existence, roughly 50 shares are currently held short) or 0.0677% of the tradable shares (for every 100,000 tradable Denali Therapeutics shares, roughly 68 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Denali Therapeutics.
Find out more about how you can short Denali Therapeutics stock.
Denali Therapeutics share dividends
We're not expecting Denali Therapeutics to pay a dividend over the next 12 months.
Denali Therapeutics share price volatility
Over the last 12 months, Denali Therapeutics's shares have ranged in value from as little as $22.75 up to $93.94. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Denali Therapeutics's is 1.9155. This would suggest that Denali Therapeutics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Denali Therapeutics overview
Denali Therapeutics Inc. , a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. The company offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidates, including DNL201 that has completed Phase 1b clinical trials and DNL151, which are in Phase 1 and Phase 1b clinical trials for Parkinson's disease. It is also developing receptor interacting serine/threonine protein kinase 1 (RIPK1) product candidates, such as DNL747, a selective and brain-penetrant small molecule RIPK1 inhibitor product candidate that is in Phase 1b clinical trial for Alzheimer's disease and amyotrophic lateral sclerosis (ALS). In addition, the company develops enzyme transport vehicle: iduronate 2-sulfatase, an enzyme replacement therapy program for MPS II, a lysosomal storage disorder; antibody transport vehicle (ATV): alpha-synuclein (aSyn) program, a protein that spreads throughout the brain in Parkinson's disease; ATV: triggering receptor expressed in myeloid cells 2, a therapeutic candidate designed to rescue microglial function in Alzheimer's disease; and ATV: Tau, a therapeutic targeting the spreading of Tau. Denali Therapeutics Inc. has collaboration agreement with Takeda Pharmaceutical Company and Genentech, Inc.
Stocks similar to Denali Therapeutics
Denali Therapeutics in the news
Biotech Bonanza: Promising Second Half Outlook
First Week of DNLI March 2022 Options Trading
First Week of DNLI March 2022 Options Trading
Frequently asked questionsWhat percentage of Denali Therapeutics is owned by insiders or institutions?
Currently 16.734% of Denali Therapeutics shares are held by insiders and 76.697% by institutions. How many people work for Denali Therapeutics?
Latest data suggests 311 work at Denali Therapeutics. When does the fiscal year end for Denali Therapeutics?
Denali Therapeutics's fiscal year ends in December. Where is Denali Therapeutics based?
Denali Therapeutics's address is: 161 Oyster Point Boulevard, South San Francisco, CA, United States, 94080 What is Denali Therapeutics's ISIN number?
Denali Therapeutics's international securities identification number is: US24823R1059 What is Denali Therapeutics's CUSIP number?
Denali Therapeutics's Committee on Uniform Securities Identification Procedures number is: 24823R105
More guides on Finder
How to buy Clover Finance (CLV) in the US
This guide will show you step-by-step instructions on how to buy the Clover Finance (CLV) token as well as a list of exchanges you can trade it on.
How to buy AT-and-T (T) stock
Steps to owning and managing T, with 24-hour and historical pricing before you buy.
How to buy Hellenic Coin (HNC) in the US
This guide will show you step-by-step instructions on how to buy the Hellenic Coin (HNC) token as well as a list of exchanges you can trade it on.
How to buy Maro (MARO) in the US
This guide will show you step-by-step instructions on how to buy the Maro (MARO) token as well as a list of exchanges you can trade it on.
How to buy Ethernity Chain (ERN) in the US
This guide will show you step-by-step instructions on how to buy the Ethernity Chain (ERN) token as well as a list of exchanges you can trade it on.
How to buy Shopping.io (SPI) in the US
This guide will show you step-by-step instructions on how to buy the Shopping.io (SPI) token as well as a list of exchanges you can trade it on.
How to buy LUKSO Token (LYXE) in the US
This guide will show you step-by-step instructions on how to buy the LUKSO Token (LYXE) token as well as a list of exchanges you can trade it on.
How to buy KardiaChain (KAI) in the US
This guide will show you step-by-step instructions on how to buy the KardiaChain (KAI) token as well as a list of exchanges you can trade it on.
How to buy Neutrino USD (USDN) in the US
This guide will show you step-by-step instructions on how to buy the Neutrino USD (USDN) token as well as a list of exchanges you can trade it on.
How to buy Venus BTC (VBTC) in the US
This guide will show you step-by-step instructions on how to buy the Venus BTC (VBTC) token as well as a list of exchanges you can trade it on.
Ask an Expert